Submitted May 12, 2008
Accepted September 3, 2008
Androgen depletion increases the efficacy of bone marrow transplantation in ameliorating experimental autoimmune encephalomyelitis
Adele L Barnard, Ann P Chidgey, Claude C Bernard, and Richard L Boyd*
Monash Immunology and Stem Cell Laboratories (MISCL), Monash University, Clayton, Victoria, Australia
* Corresponding author; email: richard.boyd{at}med.monash.edu.au.
Bone marrow transplantation (BMT) potentially represents a novel therapy for the amelioration and even cure for Multiple Sclerosis (MS). It has important advantages over immunosuppressive drug treatments, because while effecting broad-based ablation of the immune system and autoreactive cells, it provides an important means for overcoming the resultant immunodeficiency, while possibly restoring self-tolerance. However, both of these benefits are predicated on a functional thymus which undergoes profound age-induced atrophy from puberty. Reversal of thymic atrophy has been achieved by a number of procedures, including removal of sex steroids by surgical or chemical (LHRH-agonist) castration.1 Using a murine model of MS, experimental autoimmune encephalomyelitis (EAE), we combined BMT with androgen depletion to induce immune regeneration, and investigated the kinetics of increased thymic function on immune reconstitution and disease reduction. We show that androgen depletion significantly increased the efficacy of BMT to ameliorate the clinical signs of EAE whilst concurrently restoring the periphery with increased naive and regulatory lymphocytic populations. Upon re-challenge, mice with a regenerated thymus had a slower onset of clinical symptoms compared with mice receiving BMT only. These results suggest that thymic regeneration strategies may be used as a complement to conventional BMT protocols for the treatment of MS.
